Live attenuated influenza vaccine (2022)
A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE (DHSC)
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 2 year
- Value
- £1
- Sector
- HEALTH
- Published
- 11 Aug 2022
- Delivery
- 01 Aug 2022 to 31 Jul 2024
- Deadline
- 11 Feb 2022 13:00
Concepts
Location
Geochart for 1 buyers and 1 suppliers
1 buyer
1 supplier
- Astrazeneca Cambridge Biomedical Campus
Description
The provision of a live attenuated influenza vaccine. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Award Detail
1 | Astrazeneca (Cambridge Biomedical Campus)
|
CPV Codes
- 33651660 - Influenza vaccines
Other Information
Award documents LAIV Award documents LAIV.zip
Reference
- CF-0983800D0O000000rwimUAA
- CF 769ccbb4-b161-4086-8c55-f7eff3ea73d1